HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Postoperative analgesic and behavioral effects of intranasal fentanyl, intravenous morphine, and intramuscular morphine in pediatric patients undergoing bilateral myringotomy and placement of ventilating tubes.

AbstractBACKGROUND:
Bilateral myringotomy and placement of ventilating tubes (BMT) is one of the most common pediatric surgical procedures in the United States. Many children who undergo BMT develop behavioral changes in the postanesthesia care unit (PACU) and require rescue pain medication. The incidence of these changes is lower in children receiving intraoperative opioids by the nasal, IM, or IV route compared with placebo. However, there are no data to indicate which route of administration is better. Our study was designed to compare the immediate postoperative analgesic and behavioral effects of 3 frequently used intraoperative techniques of postoperative pain control for patients undergoing BMT under general anesthesia.
METHODS:
One hundred seventy-one ASA physical status I and II children scheduled for BMT were randomized into 1 of 3 groups: group 1-nasal fentanyl 2 μg/kg with IV and IM saline placebo; group 2-IV morphine 0.1 mg/kg with nasal and IM placebo; or group 3-IM morphine 0.1 mg/kg with nasal and IV placebo. All subjects received a standardized general anesthetic with sevoflurane, N(2)O, and O(2) and similar postoperative care. The primary end point of the study was the pain scores measured by the Faces, Legs, Activity, Cry, and Consolability (FLACC) scale in the PACU.
RESULTS:
There were no significant differences in peak FLACC pain among the 3 groups (mean [95% CI] 2.0 [1.2-2.8] for intranasal fentanyl, 2.7 [1.7-3.6] for IV morphine, and 2.9 [2.1-3.7] for IM morphine, respectively). There were no differences in the scores on the Pediatric Anesthesia Emergence Delirium (PAED) scale, incidence of postoperative emergence delirium (PAED score ≥ 12), emesis, perioperative hypoxemia, or need for airway intervention, and postoperative rescue analgesia. There were also no differences in the duration of PACU stay or parental satisfaction among the groups.
CONCLUSION:
In this double-blind, double-dummy study, there was no difference in the efficacy of intranasal fentanyl, IM and IV morphine in controlling postoperative pain and emergence delirium in children undergoing BMT placement. The IM route is the simplest and avoids the potential for delays to establish vascular access for IV therapy and the risks of laryngospasm if intranasal drugs pass through the posterior nasopharynx and irritate the vocal cords.
AuthorsHelena K Hippard, Kalyani Govindan, Ellen M Friedman, Marcelle Sulek, Carla Giannoni, Deidre Larrier, Charles G Minard, Mehernoor F Watcha
JournalAnesthesia and analgesia (Anesth Analg) Vol. 115 Issue 2 Pg. 356-63 (Aug 2012) ISSN: 1526-7598 [Electronic] United States
PMID22669347 (Publication Type: Comparative Study, Journal Article, Randomized Controlled Trial)
Chemical References
  • Analgesics, Opioid
  • Morphine
  • Fentanyl
Topics
  • Administration, Intranasal
  • Age Factors
  • Analgesics, Opioid (administration & dosage, adverse effects)
  • Anesthesia Recovery Period
  • Chest Tubes
  • Child
  • Child Behavior (drug effects)
  • Child, Preschool
  • Delirium (etiology)
  • Double-Blind Method
  • Female
  • Fentanyl (administration & dosage, adverse effects)
  • Humans
  • Infant
  • Infant Behavior (drug effects)
  • Injections, Intramuscular
  • Injections, Intravenous
  • Intubation, Intratracheal (adverse effects, instrumentation)
  • Male
  • Morphine (administration & dosage, adverse effects)
  • Otologic Surgical Procedures (adverse effects)
  • Pain Measurement
  • Pain, Postoperative (diagnosis, etiology, prevention & control)
  • Texas
  • Time Factors
  • Treatment Outcome
  • Tympanic Membrane (surgery)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: